Variant report

Variant	esv1827802
Chromosome Location	chr19:41352936-41386480
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:358)
CpG islands
(count:429)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:358 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41370633-41370945	K562	blood:	n/a	n/a
2	ARID3A	chr19:41378197-41378436	K562	blood:	n/a	n/a
3	ATF1	chr19:41370536-41370948	K562	blood:	n/a	n/a
4	ATF1	chr19:41378237-41378485	K562	blood:	n/a	n/a
5	ATF3	chr19:41378141-41378430	K562	blood:	n/a	n/a
6	ATF3	chr19:41370620-41370877	K562	blood:	n/a	n/a
7	CBX3	chr19:41381255-41381833	K562	blood:	n/a	n/a
8	CBX3	chr19:41379821-41380148	K562	blood:	n/a	n/a
9	CBX3	chr19:41379769-41380227	K562	blood:	n/a	n/a
10	CBX3	chr19:41370123-41371107	K562	blood:	n/a	n/a
11	CCNT2	chr19:41370582-41370786	K562	blood:	n/a	n/a
12	CEBPB	chr19:41378139-41378466	K562	blood:	n/a	n/a
13	CEBPB	chr19:41373920-41374208	K562	blood:	n/a	n/a
14	CEBPB	chr19:41378202-41378474	K562	blood:	n/a	n/a
15	CEBPB	chr19:41370209-41371189	K562	blood:	n/a	chr19:41370433-41370441
16	CEBPB	chr19:41362024-41362201	K562	blood:	n/a	n/a
17	CEBPB	chr19:41368416-41368601	K562	blood:	n/a	n/a
18	CEBPB	chr19:41370543-41370910	K562	blood:	n/a	n/a
19	CEBPB	chr19:41368761-41369068	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr19:41370305-41370801	K562	blood:	n/a	chr19:41370433-41370441
21	CEBPB	chr19:41373834-41374300	A549	lung:	n/a	n/a
22	CEBPB	chr19:41374056-41374100	A549	lung:	n/a	n/a
23	CEBPB	chr19:41368480-41368982	A549	lung:	n/a	n/a
24	CEBPB	chr19:41367289-41367476	A549	lung:	n/a	n/a
25	CEBPD	chr19:41370661-41370862	K562	blood:	n/a	n/a
26	CEBPD	chr19:41370295-41371143	K562	blood:	n/a	n/a
27	CTCF	chr19:41368340-41368490	HPAF	blood vessel:	n/a	n/a
28	CTCF	chr19:41368360-41368510	K562	blood:	n/a	n/a
29	CTCF	chr19:41364081-41364360	K562	blood:	n/a	n/a
30	CTCF	chr19:41360494-41360547	Kidney_OC	kidney:	n/a	n/a
31	CTCF	chr19:41368660-41368810	A549	lung:	n/a	n/a
32	CTCF	chr19:41368400-41368550	HBMEC	blood vessel:	n/a	n/a
33	CTCF	chr19:41354520-41354670	AG04449	skin:	n/a	n/a
34	CTCF	chr19:41354520-41354670	HCFaa	heart:	n/a	n/a
35	CTCF	chr19:41368500-41368650	NHLF	lung:	n/a	n/a
36	CTCF	chr19:41386288-41386587	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr19:41367560-41367710	K562	blood:	n/a	n/a
38	CTCF	chr19:41364080-41364230	A549	lung:	n/a	n/a
39	CTCF	chr19:41354333-41354798	H1-hESC	embryonic stem cell:	n/a	chr19:41354699-41354709
40	CTCF	chr19:41354660-41354810	A549	lung:	n/a	chr19:41354699-41354709
41	CTCF	chr19:41360550-41360556	Kidney_OC	kidney:	n/a	n/a
42	CTCF	chr19:41354500-41354650	HL-60	blood:	n/a	n/a
43	CTCF	chr19:41368360-41368510	HMF	breast:	n/a	n/a
44	CTCF	chr19:41354521-41354653	ProgFib	skin:	n/a	n/a
45	CTCF	chr19:41354460-41354610	AG10803	skin:	n/a	n/a
46	CTCF	chr19:41368380-41368530	HPAF	blood vessel:	n/a	n/a
47	CTCF	chr19:41386434-41386449	K562	blood:	n/a	n/a
48	CTCF	chr19:41368380-41368530	NHEK	skin:	n/a	n/a
49	CTCF	chr19:41354442-41354722	A549	lung:	n/a	chr19:41354699-41354709
50	CTCF	chr19:41354521-41354704	Lung_OC	lung:	n/a	n/a

(count:429 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41386441-41386491	HL-60	blood:	n/a
2	chr19:41354682-41354732	HRCEpiC	kidney:	n/a
3	chr19:41386441-41386491	HL-60	blood:	n/a
4	chr19:41354682-41354732	HRCEpiC	kidney:	n/a
5	chr19:41386441-41386491	HPAEpiC	pulmonary alveolar:	n/a
6	chr19:41385865-41385915	HEK293	kidney:	embryo
7	chr19:41354553-41354603	BJ	skin:	n/a
8	chr19:41386441-41386491	HCT-116	colon:	n/a
9	chr19:41354553-41354603	GM12892	blood:	n/a
10	chr19:41355973-41356023	HMEC	breast:	n/a
11	chr19:41354553-41354603	Caco-2	colon:	n/a
12	chr19:41354682-41354732	NB4	blood:	n/a
13	chr19:41383654-41383704	PrEC	prostate:	n/a
14	chr19:41383654-41383704	AG04450	lung:	fetal
15	chr19:41354553-41354603	K562	blood:	n/a
16	chr19:41385865-41385915	AG04450	lung:	fetal
17	chr19:41354682-41354732	HCT-116	colon:	n/a
18	chr19:41386441-41386491	ProgFib	skin:	n/a
19	chr19:41386441-41386491	Caco-2	colon:	n/a
20	chr19:41385865-41385915	SK-N-SH_RA	brain:	n/a
21	chr19:41385865-41385915	GM12891	blood:	n/a
22	chr19:41354142-41354192	AG09309	skin:	n/a
23	chr19:41354553-41354603	SK-N-SH_RA	brain:	n/a
24	chr19:41355973-41356023	T-47D	breast:	n/a
25	chr19:41354142-41354192	GM19239	blood:	n/a
26	chr19:41354553-41354603	NHDF-neo	bronchial:	n/a
27	chr19:41354553-41354603	SKMC	muscle:	n/a
28	chr19:41355973-41356023	SKMC	muscle:	n/a
29	chr19:41386441-41386491	GM12878	blood:	n/a
30	chr19:41385865-41385915	MCF-7	breast:	n/a
31	chr19:41355973-41356023	NT2-D1	testis:	n/a
32	chr19:41355973-41356023	NHBE	bronchial:	n/a
33	chr19:41355973-41356023	HepG2	liver:	n/a
34	chr19:41383654-41383704	PANC-1	pancreas:	n/a
35	chr19:41385865-41385915	HCPEpiC	choroid plexus:	n/a
36	chr19:41386441-41386491	NT2-D1	testis:	n/a
37	chr19:41383654-41383704	CMK	blood:	n/a
38	chr19:41385865-41385915	MCF10A-Er-Src	breast:	n/a
39	chr19:41354142-41354192	HRE	kidney:	n/a
40	chr19:41355973-41356023	MCF10A-Er-Src	breast:	n/a
41	chr19:41386441-41386491	PrEC	prostate:	n/a
42	chr19:41386441-41386491	HRPEpiC	eye:	n/a
43	chr19:41354682-41354732	T-47D	breast:	n/a
44	chr19:41385865-41385915	NB4	blood:	n/a
45	chr19:41383654-41383704	HCM	heart:	n/a
46	chr19:41383654-41383704	BJ	skin:	n/a
47	chr19:41355973-41356023	HPAEpiC	pulmonary alveolar:	n/a
48	chr19:41354553-41354603	LNCaP	prostate:	n/a
49	chr19:41354142-41354192	BJ	skin:	n/a
50	chr19:41383654-41383704	SK-N-SH	brain:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:4474827..4477394-chr19:41351022..41353007,2	MCF-7	breast:
2	chr19:41195484..41197379-chr19:41368669..41371255,2	K562	blood:
3	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:
4	chr19:41369230..41371017-chr19:41372027..41374078,2	K562	blood:

No data

Variant related genes	Relation type
CYP2A6	TF binding region
CYP2A7	TF binding region
CYP2A6	CpG island
CYP2A7	CpG island
ENSG00000103423	chromatin interactions
ENSG00000262246	chromatin interactions
ENSG00000105245	chromatin interactions

Extended variants
information (count: 1713 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:1713 , 50 per page) page: 1 2 3 4 5 6 7 ... 35

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs28399448	chr19:41352936-41352937	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs111033610	chr19:41352941-41352942	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs372866943	chr19:41352965-41352966	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs376628808	chr19:41352966-41352967	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs371160651	chr19:41352976-41352977	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs373242426	chr19:41352992-41352993	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs555186829	chr19:41352996-41352997	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs201792681	chr19:41353000-41353001	Weak transcription Strong transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs138844279	chr19:41353017-41353018	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs562491463	chr19:41353050-41353051	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs2453799	chr19:41353071-41353072	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs2453800	chr19:41353094-41353095	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs75047183	chr19:41353102-41353103	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs56113850	chr19:41353107-41353108	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	disease
15	rs560445731	chr19:41353109-41353110	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs527495675	chr19:41353136-41353137	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs542814609	chr19:41353145-41353146	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs56006279	chr19:41353146-41353147	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs529372394	chr19:41353152-41353153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs547500410	chr19:41353170-41353171	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs559914206	chr19:41353176-41353177	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs569231510	chr19:41353197-41353198	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs193119488	chr19:41353204-41353205	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs60844121	chr19:41353219-41353220	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs551667439	chr19:41353247-41353248	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs566790786	chr19:41353316-41353317	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs56267346	chr19:41353338-41353339	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs56100930	chr19:41353411-41353412	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs376662737	chr19:41353487-41353488	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs371558937	chr19:41353495-41353496	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs112253660	chr19:41353564-41353565	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs567286959	chr19:41353567-41353568	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs55734469	chr19:41353579-41353580	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs537939928	chr19:41353605-41353606	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs72549440	chr19:41353611-41353612	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs367831875	chr19:41353623-41353624	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs199999881	chr19:41353625-41353626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs199612912	chr19:41353627-41353628	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs577720071	chr19:41353630-41353631	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs544984580	chr19:41353657-41353658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs554129636	chr19:41353727-41353728	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs572348346	chr19:41353743-41353744	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs371639289	chr19:41353800-41353801	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs55995653	chr19:41353838-41353839	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs542490761	chr19:41353844-41353845	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs2388868	chr19:41353849-41353850	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
47	rs397833727	chr19:41353883-41353884	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs2545782	chr19:41353889-41353890	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs55921593	chr19:41353897-41353898	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs201920184	chr19:41353915-41353916	Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:259 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41349800-41353800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:41350000-41353000	Strong transcription	Liver	Liver
3	chr19:41350600-41354400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
4	chr19:41350800-41354400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
5	chr19:41351000-41354600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
6	chr19:41351200-41354400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
7	chr19:41351200-41354400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
8	chr19:41351400-41354200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
9	chr19:41352800-41353000	Enhancers	Lung	lung
10	chr19:41352800-41354400	Weak transcription	Pancreas	Pancrea
11	chr19:41353000-41353600	Weak transcription	Lung	lung
12	chr19:41353000-41354000	Weak transcription	Liver	Liver
13	chr19:41353600-41354800	Enhancers	Lung	lung
14	chr19:41353800-41354000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
15	chr19:41353800-41354200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr19:41353800-41354200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr19:41353800-41354800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
18	chr19:41354000-41354200	Enhancers	Liver	Liver
19	chr19:41354000-41354800	Enhancers	Spleen	Spleen
20	chr19:41354200-41354400	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
21	chr19:41354200-41354400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr19:41354200-41354400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
23	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr19:41354200-41354400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
25	chr19:41354200-41354400	Enhancers	Ovary	ovary
26	chr19:41354200-41354600	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
27	chr19:41354200-41354600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr19:41354200-41354600	Flanking Active TSS	Liver	Liver
29	chr19:41354200-41354800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
30	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
31	chr19:41354200-41354800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
32	chr19:41354200-41354800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
33	chr19:41354200-41355000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
34	chr19:41354200-41355000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
35	chr19:41354400-41354600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
36	chr19:41354400-41354600	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
37	chr19:41354400-41354600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
38	chr19:41354400-41354600	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
39	chr19:41354400-41354600	Bivalent Enhancer	Fetal Brain Male	brain
40	chr19:41354400-41354600	Flanking Active TSS	Ovary	ovary
41	chr19:41354400-41354600	Enhancers	Rectal Smooth Muscle	rectum
42	chr19:41354400-41354600	Enhancers	Right Ventricle	heart
43	chr19:41354400-41354600	Bivalent Enhancer	Stomach Mucosa	stomach
44	chr19:41354400-41354800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
45	chr19:41354400-41354800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr19:41354400-41354800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
47	chr19:41354400-41354800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
48	chr19:41354400-41354800	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
49	chr19:41354400-41354800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr19:41354400-41354800	Active TSS	Brain Angular Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links